for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Medtech Insight
   Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1876-8008
     Published by Informa plc Homepage  [13 journals]
  • Heart Failure: Next-Gen VADs Fuel Optimism Amid Challenges
    • Abstract: Although near-term challenges have slowed growth in the market for left ventricular assist devices (LVADs), companies are developing new, less invasive VADs with improved pump designs to further improve patient outcomes and allow for a wider application of the therapy in treating heart failure. These next-generation VADs are fueling long-term optimism in the market for mechanical circulatory support, which remains one of the more attractive opportunities in the cardiovascular space.
      PubDate: Tue, 16 Dec 2014 00:05:11 -050
       
  • Plastic Surgery Market: Fat Grafting Grabs A Hefty Slice Of The Plastics
           Pie
    • Abstract: Fat, fillers, and a "funnel" that may minimize a common cause of breast implant complications are among the hot topics in both aesthetic and reconstructive plastic surgery. Meanwhile, the acquisition by Actavis of Allergan – a leading player in the aesthetics market with BOTOX and breast implants – has the combined company poised for long-term double-digit revenue and earnings growth.
      PubDate: Tue, 16 Dec 2014 00:05:04 -050
       
  • Device, Diagnostic Makers See Great Potential In Dry Eye Disease
    • Abstract: Dry eye disease often has gone undiagnosed and untreated, but that’s beginning to change. Patients are asking for better remedies, and the medtech industry is beginning to meet that demand with diagnostics and devices to augment the exceedingly thin armamentarium.
      PubDate: Tue, 16 Dec 2014 00:05:01 -050
       
  • TAVR Market Shifting Into High Gear
    • Abstract: Momentum is building in the burgeoning and rapidly evolving transcatheter aortic valve replacement (TAVR) market. With a growing body of clinical evidence, the potential for expanded indications in lower-risk patients, and more favorable reimbursement on the horizon, the TAVR market is shifting into high gear, with solid, double-digit growth ahead.
      PubDate: Tue, 16 Dec 2014 00:00:53 -050
       
  • Treating Ebola And Beyond: Spotlight On Novel Hemopurifier
    • Abstract: Aethlon Medical’s Hemopurifier device was successfully used in Germany to treat a Ugandan physician with Ebola, and now the company is preparing to launch its first human clinical studies in the US. Aethlon hopes this novel device will provide a first-in-class broad-spectrum treatment countermeasure against pandemic threats such as Ebola and chronic viral pathogens.
      PubDate: Tue, 16 Dec 2014 00:00:48 -050
       
  • OtoKinetics: Stimulating Cochlear Fluid To Improve Hearing
    • Abstract: Currently, people with severe hearing loss are treated with conventional hearing aids, which have less than a 50% success rate due to such problems as feedback and discomfort. OtoKinetics Inc. hopes to increase that efficacy rate to at least 90% with its Krescendo implant, a titanium device about the size of a grain of rice that is inserted into the cochlea.
      PubDate: Tue, 16 Dec 2014 00:00:44 -050
       
  • NanoSomiX: Blood Test For Early Alzheimer’s Detection
    • Abstract: Envision a simple blood test that can detect the presence of Alzheimer’s disease up to 10 years in advance of a standard clinical diagnosis. NanoSomiX Inc. is developing technology that evaluates brain-derived exosomes and reveals biological changes that are implicated in the pathogenesis of AD.
      PubDate: Tue, 16 Dec 2014 00:00:39 -050
       
  • FDA Green Lights Dallen Medical’s Tensyn Band
           For Shoulder Separation
    • Abstract: Dallen Medical bolstered its array of extremity products with the recent FDA clearance of its knotless banding technology Tensyn for shoulder separation, and gained access to an annual market opportunity of $25 to $30 million.
      PubDate: Tue, 16 Dec 2014 00:00:32 -050
       
  • Valencia Technologies Pioneers Crowdfunding For Hypertension Device
    • Abstract: Valencia’s new, implantable neuromodulation technology to treat hypertension is in the early stages of development, and while the device has started to attract attention based on its novel approach, the start-up’s novel fundraising method is also causing the industry to take notice.
      PubDate: Tue, 16 Dec 2014 00:00:28 -050
       
  • New Foley-Based Monitor For Early Detection Of Sepsis
    • Abstract: Consano Medical is moving closer to FDA clearance for its Canary Catheter, a novel, continuous monitoring device that leverages an existing urinary catheter for the early detection of sepsis – a serious condition that costs hospitals more than $20 billion annually in the US alone.
      PubDate: Tue, 16 Dec 2014 00:00:18 -050
       
  • Medical Device Deals Update, November-December 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2014.
      PubDate: Tue, 16 Dec 2014 00:00:06 -050
       
  • Medtech Execs On The Move, November-December 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 16 Dec 2014 00:00:00 -050
       
  • ESC 2014 Shines Spotlight On The Future Of Cardiology
    • Abstract: The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.
      PubDate: Thu, 30 Oct 2014 00:05:34 -040
       
  • Digital Health Pushing Telemedicine To Center Stage
    • Abstract: Remote monitoring is proving to be the driving force in the industry’s quest to reduce costs by keeping patients out of hospitals, and telemedicine is positioned to become a major part of that scheme. However, telemedicine has a number of components and players, and while the market offers opportunities, it could also prove to be somewhat disruptive to companies and products that do not fit in the envisioned landscape.
      PubDate: Thu, 30 Oct 2014 00:05:19 -040
       
  • Oxford Performance Materials: Is 3D Printing The New Face Of
           Orthopedics'
    • Abstract: With FDA approval of facial and cranial implants, Oxford Performance Materials, a materials and additive manufacturing (3D printing) company, is working to become a full service orthopedic and spinal company in the coming years.
      PubDate: Thu, 30 Oct 2014 00:05:06 -040
       
  • Stenting And Thrombectomy Systems Fuel Neuro Device Market Growth
    • Abstract: Advances in distally protected carotid artery stenting systems and second-generation cerebral thrombectomy devices will help drive strong growth in the US neurointerventional device market over the next five years. The market, which includes endovascular devices for the treatment of cerebral aneurysms, arteriovenous malformations, stroke, and carotid artery disease, is projected to grow at a compound annual rate of 6.5%, and reach more than $846 million by 2018.
      PubDate: Thu, 30 Oct 2014 00:05:02 -040
       
  • SolaranRx: Theranostics For Metastatic Melanoma
    • Abstract: SolaranRx Inc. is jumping on the theranostics bandwagon by tackling the deadly skin cancer melanoma, which for advanced cases has a staggering survival rate of only six months and a one-year mortality of 75%. The company’s lead compound, SRX-1177, is a novel peptide linked to a radioisotope that can preferentially attach to melanocortin-1, a unique receptor overexpressed on melanoma cells.
      PubDate: Thu, 30 Oct 2014 00:00:49 -040
       
  • Niveus Medical: Thermally Enhanced Muscle Stimulation
    • Abstract: The Muscle Stimulation System 110 from Niveus Medical Inc. combines electricity with localized cooling in the treatment area to help prevent atrophy and associated deconditioning in hospital patients facing extended periods of bed rest.
      PubDate: Thu, 30 Oct 2014 00:00:45 -040
       
  • AcuFocus Provides Pair of Solutions for Presbyopia Market
    • Abstract: AcuFocus Inc. is using “small aperture” technology to provide solutions for the vast presbyopia market. The company is poised to potentially be the first to enter the US market with a cornea inlay – pending FDA approval.
      PubDate: Thu, 30 Oct 2014 00:00:31 -040
       
  • Exact Sciences Launches First Stool-Based DNA Screening Test For
           Colorectal Cancer
    • Abstract: With the cost of treating colon cancer in the US projected to reach $20 billion annually by 2020, Exact Sciences hopes to improve colorectal cancer screening and survival rates with Cologuard, the first FDA-cleared noninvasive screening test that analyzes both DNA and blood biomarkers in stool.
      PubDate: Thu, 30 Oct 2014 00:00:18 -040
       
  • St. Jude Medical Expands Presence In Electrophysiology Market With New
           Advanced Ablation Catheter
    • Abstract: St. Jude Medical expands its presence in the electrophysiology market after gaining European regulatory approval of FlexAbility, the company’s next-generation flexible ablation catheter, and expects to receive US FDA 510(k) clearance for the device by year-end.
      PubDate: Thu, 30 Oct 2014 00:00:13 -040
       
  • Medtech Execs On The Move, October 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Thu, 30 Oct 2014 00:00:08 -040
       
  • Medical Device Deals Update, October 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2014.
      PubDate: Thu, 30 Oct 2014 00:00:00 -040
       
  • Innovation And Under-Penetration Driving Global Vascular Access Markets
    • Abstract: With an annual growth of almost 5%, the market for vascular access site repair products is attracting companies with innovative new products. Wider acceptance of new approaches to wound closure by interventionalists and the under-penetration in emerging Asian markets in particular are resulting in an uptake in the use of higher-tech devices and the emergence of local manufacturers.
      PubDate: Tue, 30 Sep 2014 00:05:27 -040
       
  • Who’s Next' Ten Potential Medtech Takeover Targets
    • Abstract: Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
      PubDate: Tue, 30 Sep 2014 00:05:12 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014